Active	Status	Sponsor type	Region	Phase	Filter
3 Active 16 Inactive 19 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zyflo (zileuton) / Chiesi
ChiCTR-OPN-16009545: Optimization of Clinical Treatment Schemes for Multidrug - resistant Pulmonary Tuberculosis Based on Host - mediate	Recruiting	4	90		Chemotherapy + Zyflo stay through ;Chemotherapy alone	Shanghai Public Health Clinical Center; Shanghai Public Henlth Cinical Center, Special funds	Multi drug resistant pulmonary tuberculosis
NCT04996199: Comparision Efficacy of Carbamazepine & Oxcarbazepine in the Treatment of Trigeminal Neuralgia- a Randomised Clinical Trial	Recruiting	4	132	RoW	Oxcarbazepine, LOVAX, Carbamazepine, zileuton	Postgraduate Institute of Dental Sciences Rohtak	Trigeminal Neuralgia	12/21	01/22
ACTRN12606000320550: Zileuton therapy for Sjogren-Larsson syndrome	Recruiting	N/A	3			South East Sydney Area Health Service, Sydney Children Hospital, Critical Therapeutics Inc	Sjogren-Larsson syndrome